PRIMA, non nocere

Affiliations

¹ McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
² McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: lillian.s.kao@uth.tmc.edu.

Comment

John A Harvin et al. Lancet. 2017.

. 2017 Aug 5;390(10094):535-536.

doi: 10.1016/S0140-6736(17)31616-1. Epub 2017 Jun 20.

¹ McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
² McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Electronic address: lillian.s.kao@uth.tmc.edu.

No abstract available

Comment in

PRIMA, non nocere: a reply from the authors.
Jairam AP, Timmermans L, Lange JF, Jeekel J. Jairam AP, et al. Lancet. 2018 May 5;391(10132):1771-1772. doi: 10.1016/S0140-6736(18)30782-7. Lancet. 2018. PMID: 29739561 No abstract available.

Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial.
Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, Steyerberg EW, Timman R, van der Ham AC, Dawson I, Charbon JA, Schuhmacher C, Mihaljevic A, Izbicki JR, Fikatas P, Knebel P, Fortelny RH, Kleinrensink GJ, Lange JF, Jeekel HJ; PRIMA Trialist Group. Jairam AP, et al. Lancet. 2017 Aug 5;390(10094):567-576. doi: 10.1016/S0140-6736(17)31332-6. Epub 2017 Jun 20. Lancet. 2017. PMID: 28641875 Clinical Trial.